Medicus Pharma Ltd.
Close on Oct 19, 2026
- Market cap
- $146.17M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Medicus Pharma has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Medicus Pharma filed with the SEC
MEDICUS PHARMA LTD. ENTERS INTO $5.1 MILLION WARRANT
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. APPOINTS CAROLYN BONNER AS CHIEF
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. PROVIDES CORPORATE UPDATES AND
Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES $8.0 MILLION
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. COMPLETES ACQUISITION OF ANTEV LIMITED
Acquisition or disposition completed · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. PROVIDES UPDATE ON DOXORUBICIN
Unregistered share sale · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES A MEMORANDUM OF
Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES VOTING RESULTS FOLLOWING THE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS
Shareholder vote results · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD ANNOUNCES A DEFINITIVE AGREEMENT TO
Material agreement · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES APPOINTMENT OF ANDREW
Executive or director change · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES PRICING OF $7.0 MILLION PUBLIC
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES CLOSING OF $7.0 MILLION PUBLIC
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
MEDICUS PHARMA LTD ANNOUNCES A BINDING LETTER OF
Other events · EX-99.1 to Form 8-K
To All Applicable Exchanges and Securities Administrators
Other events · EX-99.1 to Form 8-K
To All Applicable Exchanges and Securities Administrators
Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES PRICING OF $4.2 MILLION REGULATION A OFFERING
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
MEDICUS PHARMA LTD. ANNOUNCES CLOSING OF $4.2 MILLION REGULATION A OFFERING
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
MEDICUS PHARMA LTD. ENTERS INTO STANDBY EQUITY PURCHASE
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
NOTICE OF CHANGE OF AUDITOR
EX-99.1 to Form 6-K
Financial and Consumer Affairs Authority of Saskatchewan
EX-99.2 to Form 6-K
130 North 18th Street, Suite 3000
EX-99.3 to Form 6-K
Condensed Consolidated Interim Financial Statements
EX-99.2 to Form 6-K
MEDICUS PHARMA LTD. ANNOUNCES PRICING OF US$4.0M INITIAL
EX-99.1 to Form 6-K
MEDICUS PHARMA LTD. ANNOUNCES CLOSING OF US$4.0M
EX-99.2 to Form 6-K
Odyssey Transfer and Trust Company, as
EX-99.3 to Form 6-K
MEDICUS PHARMA LTD. ANNOUNCES PRICING OF US$4.0M INITIAL
EX-99.1 to Form 6-K
MEDICUS PHARMA LTD. ANNOUNCES CLOSING OF US$4.0M
EX-99.2 to Form 6-K
Odyssey Transfer and Trust Company, as
EX-99.3 to Form 6-K